Systemic sclerosis & Raynaud's

Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

Arthritis Care Res (Hoboken)Published Psychometric validation study

Authors' conclusion

The CD-RISC-10 is a valid and reliable measure of resilience in SSc, with score comparability across English and French versions.

Study context

Population
Systemic sclerosis (SSc) participants enrolled in the Scleroderma Patient-centered Intervention Network Cohort who completed the Connor-Davidson Resilience Scale (CD-RISC-10) between August 2022 and January 2023
Participants
962 participants
Comparison
English vs French versions of the CD-RISC-10
Outcome
Validity, reliability and DIF of the CD-RISC-10
Methodological detailscohort study, confirmatory factor analysis, Multiple Indicators Multiple Causes models for differential item functioning (DIF)
  • Cohort study
  • Confirmatory factor analysis
  • Multiple Indicators Multiple Causes models for DIF

Performance

As reported in the abstract

Confirmatory factor analysis (CFA) single-factor structure: Tucker-Lewis index
0.99
CFA: comparative fit index
0.99
CFA: root mean square error of approximation
0.08 (90% CI 0.07, 0.09)
Internal consistency, Cronbach's α
0.93 (95% CI 0.92, 0.94)
Correlations with other measures of psychological functioning, moderate to large, confirming hypotheses (|r|)
0.57-0.78
1-2-week test-retest reliability, intraclass correlation coefficient (ICC) (95% CI 0.75, 0.85), subsample of 230
0.80

Original publication

Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken). Published 7 June 2023. doi:10.1002/acr.25139

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.